• OBJECTIVES
    • The objective of this study was to report outcomes of the Retrograde Femoral Nail-Advanced with Lateral Attachment Washer (RFNA-LAW) (Synthes, Paoli, PA) compared with laterally locked plates (LLP) when treating AO/OTA type 33 distal femoral fractures.
  • DESIGN
    • Retrospective chart review.
  • SETTING
    • Single, academic, Level-1 Trauma Center.
  • PATIENT SELECTION CRITERIA
    • All adult patients who had fixation of an AO/OTA type 33 distal femoral fracture with the RFNA-LAW combination or LLP from 2018 to 2023 with follow-up to union or a minimum of 1 year.
  • OUTCOME MEASURES AND COMPARISONS
    • The main outcome measure was union. Secondary outcomes included implant failure, infection, and alignment immediately postoperatively and at final follow-up. Primary and secondary outcome measures were compared between the RFNA-LAW and LLP groups.
  • RESULTS
    • Forty-eight patients (19 female) with a mean age of 56 years (range 19-94 years) were in the RFNA-LAW group. Fifty-three patients (29 female) with a mean age of 66 years (24-91 years) were in the LLP group. There were no significant differences when comparing body mass index, diabetes, smoking status, mechanism of injury, or fracture classification between groups ( P > 0.05). There was no difference in immediate, postoperative alignment ( P = 0.49). When comparing anatomic lateral distal femoral angle measurements at final follow-up, there was significantly more malalignment in the LLP group ( P = 0.005). There were 8 implant failures (15%) in the LLP group compared with 1 in the RFNA-LAW group (2%) ( P = 0.02). There were 14 reoperations (26%) in the LLP group compared with 4 (8%) in the RFNA-LAW group ( P = 0.02).
  • CONCLUSIONS
    • The Retrograde Nail Advanced-Lateral Attachment Washer combination demonstrated a high union rate when treating complex fractures of the distal femur. When compared with lateral locked plating, this implant combination demonstrated significantly lower rates of nonunion and reoperation.
  • LEVEL OF EVIDENCE
    • Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.